Edmond De Rothschild Holding S.A. Avadel Pharmaceuticals PLC Transaction History

Edmond De Rothschild Holding S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$6.61 - $10.07 $26,440 - $40,280	-4,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$5.03 - $7.95 $20,120 - $31,800	4,000 New	4,000 $27,000
Q1 2019 May 13, 2019	SELL	$1.44 - $3.29 $7,632 - $17,437	-5,300 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$6.76 - $11.7 $17,914 - $31,004	2,650 Added 100.0%	5,300 $39,000
Q4 2017 Feb 14, 2018	BUY	$8.03 - $11.25 $21,279 - $29,812	2,650	2,650 $22,000

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $626M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.